Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Alveolar Bone Engineering Using Bioactive Glass (Sol-Gel) Immediately After Premolar Extraction in Patients Requiring Orthodontic Treatment

NCT01878084 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT01878084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01878084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Alveolar Bone Engineering Using Bioactive Glass (Sol-Gel) Immediately After Premolar Extraction in Patients Requiring Orthodontic Treatment
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
January 31, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss, horizontal alveolar bone loss, vertical alveolar bone loss